Related Experiment Videos
Antimycobacterial evaluation of germacranolides
N H Fischer1, T Lu, C L Cantrell
1Department of Chemistry, Louisiana State University, Baton Rouge 70803-1804, USA. fischer@chemgate.chem.lsu.edu
Phytochemistry
|September 25, 1998
Summary
Sesquiterpene lactones show potential against Mycobacterium tuberculosis and M. avium. The alpha-methylene-gamma-lactone structure is key for this in vitro activity.
Area of Science:
- Natural Product Chemistry
- Microbiology
- Medicinal Chemistry
Background:
- Mycobacterium tuberculosis and M. avium are significant pathogens.
- Sesquiterpene lactones are a class of natural products with diverse biological activities.
- Previous research suggests some sesquiterpene lactones possess antimicrobial properties.
Purpose of the Study:
- To determine the minimum inhibitory concentrations (MIC) of various germacranolide-type sesquiterpene lactones against Mycobacterium tuberculosis and M. avium.
- To investigate the structure-activity relationships (SAR) of these compounds.
- To identify key structural features responsible for in vitro antimycobacterial activity.
Main Methods:
- A radiorespirometric bioassay was employed to measure MIC values.
- A panel of natural and semisynthetic germacranolide-type sesquiterpene lactones and their derivatives were tested.
- Structure-activity relationship studies were conducted based on the tested compounds.
Main Results:
- Parthenolide, costunolide, and 1(10)-epoxycostunolide exhibited varying levels of inhibitory activity.
- The alpha-methylene-gamma-lactone moiety was identified as an essential structural component for activity.
- This moiety alone was not sufficient to confer significant in vitro activity against M. tuberculosis and M. avium.
Conclusions:
- The alpha-methylene-gamma-lactone group is a critical pharmacophore for antimycobacterial activity in sesquiterpene lactones.
- Further structural modifications may be necessary to optimize the potency and efficacy of these compounds.
- Sesquiterpene lactones represent a promising class of compounds for the development of new anti-mycobacterial agents.